A platform that enables insights and collaboration across the life sciences enterprise.
As the biopharma landscape grows and evolves in the age of New science, life sciences industry leaders are finding new opportunities to raise the standard and personalization of patient care. INTIENT enables the continuity and flow of information across the enterprise, providing the right data, at the right time, to the right team.
Data access is just the first step. Accenture INTIENT enables the application of artificial intelligence and advanced analytics to that data—delivering insights that can lead to better patient outcomes, faster than ever before.
[NEWS] INTIENT COLLABORATION EARNS GOOGLE AWARD
Google Cloud Industry Solutions Partner of the Year
INTIENT Research product suite demo
View TranscriptINTIENT Clinical product suite demo
View TranscriptINTIENT Pharmacovigilance product suite demo
View TranscriptINTIENT Patient product suite demo
View TranscriptINTIENT has four key components spanning research and development through patient services.
Looking to glean more from your data? Or gain access to new information? INTIENT will help unlock actionable insights, helping you succeed and impact patients’ lives.
Offers trusted and compliant digital health and patient data ingestion, storage and processing across functions, geographies and regulatory agencies.
Empowers seamless collaboration across the enterprise—from research to commercial—to unify teams with common insights and objectives.
Leverages industry-leading, cloud-based infrastructure with open interfaces to enable flexible adoption with existing systems.
Enables the application of artificial intelligence, smart automation, machine learning and advanced analytics to discover and apply new insights.
Provides ready access to our external partner network of digital innovation, removing barriers to entry for technology, data and service providers.
Trusted as the platform of choice by eight of the 10 global life sciences companies.
IDC, a global provider of market intelligence and advisory services, recently surveyed 120 pharmaceutical and biotechnology leaders regarding their strategic approaches toward technology and data in their businesses. View the survey results.
94%
Pharmaceutical and biotechnology leaders said the ability to easily access, use and apply analytics and AI to data from across functional areas was important to achieving their business strategy.
74%
of pharmaceutical and biotechnology leaders feel that improving their ability to connect, share and analyze data from across the organization is critical to their company’s success.
OVER50%
Yet, more than 50 percent said they do not have a clear path toward achieving that goal to connect, share and analyze data from across the organization.
Source: IDC Survey, sponsored by Accenture, The Case for Connectivity in the Life Sciences, 2019
On demand video series focused on the INTIENT Platform.
INTIENT Platform On Demand Webinar
This webinar provides an overview of the INTIENT Platform.
View TranscriptINTIENT Patient Product Suite On Demand Webinar
This webinar focuses on the INTIENT Patient Product Suite.
View TranscriptINTIENT Research Product Suite On Demand Webinar
This webinar focuses on the INTIENT Research Product Suite.
View TranscriptINTIENT Clinical Product Suite On Demand Webinar
This webinar focuses on the INTIENT Clinical Product Suite.
View TranscriptINTIENT Pharmacovigilance On Demand Webinar
This webinar focuses on the INTIENT Pharmacovigilance Product Suite.
View TranscriptKnowledge of trends and insights are important to Accenture. Join our live thought leader-hosted events and watch on-demand sessions.
BioSymetrics, a biomedical artificial intelligence company that helps researchers develop drugs with greater speed and precision, announced it has joined Accenture's partner ecosystem.
Accenture and Google Cloud announced that Google Cloud will be the cloud technology provider for Accenture’s INTIENT™ life sciences industry platform.
filter result
